UBS analyst Roger Boyd lowered the firm’s price target on Varonis (VRNS) to $30 from $60 and keeps a Buy rating on the shares. Even with the conservative outlook, Varonis is still a high-teens growth story, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRNS:
- Varonis price target lowered to $30 from $41 at RBC Capital
- Balancing SaaS Momentum and Legacy Headwinds: Why Varonis Remains a Buy with a Lowered $30 Target
- Varonis price target lowered to $27 from $41 at Morgan Stanley
- Varonis price target lowered to $32 from $42 at Baird
- Varonis price target lowered to $30 from $55 at Needham